Hengrui Medicine's GnRH receptor antagonist SHR7280 tablets was approved for clinical use
Fosun Pharma's holding subsidiary ORIN1001 tablet was approved for drug clinical trial
China Resources Pharma's China Pharmaceutical Research Innovative Drug NIP003 Tablets Obtained Clinical Approval
Chinese pharmaceutical subsidiary Tianfang Co., Ltd. Risedronate Sodium Tablets passed the consistency evaluation
A new drug for the treatment of hyperammonemia, Kaglutamic acid dispersible tablets, was declared for listing in China
Huahai Pharmaceutical's Nebivolol Tablets Obtained FDA Approval Number
Bihuan Pharmaceutical's Doxycycline Hydrochloride Tablets Passed the Consistency Evaluation of Generic Drugs
The marketing application of Shandong New Era Metformin Hydrochloride Sustained-Release Tablets was approved
100 million-level best-selling cardiovascular drug Chengdu Bitedigoxin Tablets is the first to review
"Jianzhi" $8 billion Erye Pharmaceutical Rivaroxaban Tablets Enters Administrative Approval Stage
Sildenafil Citrate Orally Disintegrating Tablets of 3 Billion Large Varieties of New Dosage Form Kelun Pharmaceuticals Approved
655 varieties passed the consistency evaluation, and tablets and capsules are still the focus
Renfu Medicine's Paracetamol and Oxycodone Sustained-Release Tablets Obtained the Approval Notice for Drug Clinical Trials
Rundu Pharmaceutical Itopride Hydrochloride Tablets Obtained Drug Registration Approval
Sinopharm Modern Nifedipine Controlled-Release Tablets and Omeprazole Enteric-Coated Tablets Pass the Consistency Evaluation of Generic Drugs
On February 22, Sinopharm Modern issued an announcement stating that the company and its wholly-owned subsidiary Sinogong Co
ZSP1273 Tablets, a subsidiary of Zhongsheng Pharmaceutical, received the US FDA Clinical Trial Approval Notice
On March 1, Zhongsheng Pharmaceutical issued a corporate announcement.
The announcement stated that recently
Shanxi: Sanjitang Glimepiride Tablets are disqualified from hanging on the net!
Enrico Ticagrelor Tablets Obtained Drug Registration Certificate
Chia Tai Tianqing Ramelteon Tablets Submitted Clinical Drug Application to Grab Takeda's Blockbuster New Drug
Tide Pharmaceutical's "Colesevelam Hydrochloride Tablets" was approved by the US ANDA